StockData
Embecta Corp. logo

Embecta Corp. (EMBC) stock

EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value
$6.43−0.10 (-1.53%)

Close on Nov 12, 2026Market cap $364.32MP/E 4.4Yield 9.33%

Embecta gross margin

Gross margin is gross profit as a percentage of revenue.

Embecta's gross margin for the twelve months ending Jun 30, 2026 was 59.0%. For fiscal 2025 it was 62.6%, against 65.5% the year before. The highest annual figure on record is 70.3% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 202562.6%−2.8
FY2024Sep 30, 202465.5%−1.4
FY2023Sep 30, 202366.9%−1.7
FY2022Sep 30, 202268.6%−0.1
FY2021Sep 30, 202168.7%−1.6
FY2020Sep 30, 202070.3%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 202656.4%−10.3
Q2 FY2026CQ1 2026Mar 31, 202657.6%−5.7
Q1 FY2026CQ4 2025Dec 31, 202561.9%+1.9
Q4 FY2025CQ3 2025Sep 30, 202560.0%−0.7
Q3 FY2025CQ2 2025Jun 30, 202566.7%−3.1
Q2 FY2025CQ1 2025Mar 31, 202563.4%−1.2
Q1 FY2025CQ4 2024Dec 31, 202460.0%−7.1
Q4 FY2024CQ3 2024Sep 30, 202460.7%−3.7
Q3 FY2024CQ2 2024Jun 30, 202469.8%+3.5
Q2 FY2024CQ1 2024Mar 31, 202464.6%−3.9
Q1 FY2024CQ4 2023Dec 31, 202367.0%−1.4
Q4 FY2023CQ3 2023Sep 30, 202364.5%+0.1
Q3 FY2023CQ2 2023Jun 30, 202366.2%−3.5
Q2 FY2023CQ1 2023Mar 31, 202368.5%−1.2
Q1 FY2023CQ4 2022Dec 31, 202268.5%−2.0
Q4 FY2022CQ3 2022Sep 30, 202264.4%−5.5
Q3 FY2022CQ2 2022Jun 30, 202269.7%+1.0
Q2 FY2022CQ1 2022Mar 31, 202269.7%+0.6
Q1 FY2022CQ4 2021Dec 31, 202170.5%+3.4
Q4 FY2021CQ3 2021Sep 30, 202169.9%–
Q3 FY2021CQ2 2021Jun 30, 202168.7%–
Q2 FY2021CQ1 2021Mar 31, 202169.1%–
Q1 FY2021CQ4 2020Dec 31, 202067.1%–

More Embecta figures

See a number that looks wrong?